Purification of adenoviral vectors by combined anion exchange and gel filtration chromatography

Journal of Gene Medicine

Volumn 11, Issue 11, 2009, Pages 978-989

  Eglon, Marc N ^a   Duffy, Aoife M ^a   O'Brien, Timothy ^a   Strappe, Padraig M ^b  

^a NATIONAL UNIVERSITY OF IRELAND   (Ireland)

^b UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Adenovirus; Chromatography; Gel filtration; HPLC; Ion exchange; Purification

Indexed keywords

ADENOVIRUS VECTOR; CESIUM CHLORIDE; GREEN FLUORESCENT PROTEIN;

ANION EXCHANGE CHROMATOGRAPHY; ARTICLE; CELL CULTURE; CELL STRAIN HEK293; CONTROLLED STUDY; DENSITY GRADIENT CENTRIFUGATION; GEL FILTRATION CHROMATOGRAPHY; GENE EXPRESSION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; INTERMETHOD COMPARISON; PRIORITY JOURNAL; VIRION; VIRUS PARTICLE; VIRUS PURIFICATION;

ADENOVIRIDAE; ANION EXCHANGE RESINS; CELL LINE; CHROMATOGRAPHY, GEL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CHROMATOGRAPHY, ION EXCHANGE; GENETIC VECTORS; HUMANS; VIRUS CULTIVATION;

ADENOVIRIDAE;

EID: 72949097270     PISSN: 1099498X     EISSN: 15212254     Source Type: Journal    
DOI: 10.1002/jgm.1383     Document Type: Article

References (24)

1. http://www.wiley.co.uk/genmed/clinical/. Journal of Gene Medicine (updated September 2008).
2. Morenweiser R. Downstream processing of viral vectors and vaccines. Gene Ther 2005; 12(Suppl 1): S103-S110.
3. Kamen A, Henry O. Development and optimization of an adenovirus production process. J GeneMed 2004; 6: S184-S192.
4. Duffy A, O'Doherty A, O'Brien T, Strappe P. Purification of adenovirus and adeno-associated virus: comparison of novel membrane-based technology to conventional techniques. Gene Ther 2005; 12(Suppl 1): S62-S72.
5. Huyghe BG, Liu X, Sutjipto S, et al. Purification of a type 5 recombinant adenovirus encoding human p53 by column chromatography. Hum Gene Ther 1995; 6: 1403-1416.
6. Blanche F, Monegier B, Faucher D, et al. Polypeptide composition of an adenovirus type 5 used in cancer gene therapy. J Chromatogr A 2001; 921: 39-48.
7. Green AP, Huang JJ, Scott MO, et al. A new scalable method for the purification of recombinant adenovirus vectors. Hum Gene Ther 2002; 13: 1921-1934.
8. Lusky M. Good manufacturing practice production of adenoviral vectors for clinical trials. Hum Gene Ther 2005; 16: 281-291.
9. Maizel JV Jr, White DO, Scharff MD. The polypeptides of adenovirus. I. Evidence for multiple protein components in the virion and a comparison of types 2, 7A, and 12. Virology 1968; 36: 115-125.
10. Shabram P, Vellekamp G, Scandella C. Purification of Adenovirus. Adenoviral Vectors for Gene Therapy. Elsevier Science: San Diego, CA, 2002.
11. Nestle M, Roberts WK. An extracellular nuclease from Serratia marcescens. I. Purification and some properties of the enzyme. J Biol Chem 1969; 244: 5213-5218.
12. Nestle M, Roberts WK. An extracellular nuclease from Serratia marcescens. II. Specificity of the enzyme. J Biol Chem 1969; 244: 5219-5225.
13. Food and Drug Administration. Biological Response Modifiers Advisory Committee Meeting no. 30: Adenovirus Titer Measurements and RCA Levels; 6 March 2000. FDA Gene Therapy Letter: Discussion of Adenovirus Vectors continued from April U.S. Food and Drug Administration, Silver Spring, MD, USA 5.
14. Gekko K, Timasheff SN. Mechanism of protein stabilization by glycerol: preferential hydration in glycerol-water mixtures. Biochemistry 1981; 20: 4667-4676.
15. Gekko K, Timasheff SN. Thermodynamic and kinetic examination of protein stabilization by glycerol. Biochemistry 1981; 20: 4677-4686.
16. Herzer S, PB, Wegman T, Moore P. Isoelectric titration curves of viral particles as an evaluation tool for ion exchange chromatography. Life Sci News Amersham Biosci 2003; 13: 16-18.
17. Philipson L. Structure and assembly of adenoviruses. Curr Top Microbiol Immunol 1984; 109: 1-52.
18. Boulanger PA, Flamencourt P, Biserte G. Isolation and comparative chemical study of structural proteins of the adenoviruses 2 and 5: hexon and fiber antigens. Eur J Biochem 1969; 10: 116-131.
19. Galdiero F. Adenovirus aggregation and preservation in extracellular environment. Arch Virol 1979; 59: 99-105.
20. Pettersson U, Philipson L, Hoglund S. Structural proteins of adenoviruses. I. Purification and characterization of the adenovirus type 2 hexon antigen. Virology 1967; 33: 575-590.
21. Evans RK, Nawrocki DK, Isopi LA, et al. Development of stable liquid formulations for adenovirus-based vaccines. J Pharm Sci 2004; 93: 2458-2475.
22. Hoganson DK, Ma JC, Asato L, et al. Development of a stable adenoviral vector formulation. Bioprocessing J 2002; 1: 43-47.
23. Gueret V, Negrete-Virgen JA, Lyddiatt A, Al-Rubeai M. Rapid titration of adenoviral infectivity by flow cytometry in batch culture of infected HEK293 cells. Cytotechnology 2002; 38: 87-97.
24. Rux JJ, Kuser PR, Burnett RM. Structural and phylogenetic analysis of adenovirus hexons by use of high-resolution x-ray crystallographic, molecular modeling, and sequence-based methods. J Virol 2003; 77: 9553-9566.